Form 4: Blueprint Medicines COO Christina Rossi Sells Shares to Cover Tax Obligations

Christina Rossi, Chief Operating Officer of Blueprint Medicines Corp, sold 6,495 shares of common stock on March 5, 2025, to cover tax withholding obligations related to vesting restricted stock units.

Summary

• On March 5, 2025, Christina Rossi, the Chief Operating Officer of Blueprint Medicines Corp, sold 6,495 shares of the company's common stock.
• The shares were sold at a price of $88.8 per share.
• The sale was executed to cover tax withholding obligations associated with the vesting of restricted stock units.
• Following the transaction, Rossi directly owns 71,540 shares of Blueprint Medicines Corp.
• The sale was not a discretionary trade but an automatic 'sell to cover' transaction to satisfy tax obligations.

Sentiment

Score: 7

Explanation: The document is a routine SEC filing related to stock sales for tax obligations, which is a neutral event. It doesn't indicate any positive or negative sentiment towards the company's performance or future prospects.

Industry Context

Sales of shares to cover tax obligations upon vesting of restricted stock units are a common practice among corporate executives and do not necessarily indicate a negative outlook on the company.

Stakeholder Impact

• The sale of shares by a company executive could be perceived negatively by some shareholders, although this transaction is primarily for tax purposes.

Key Dates